Mohamed S. Attia, Mohamed F. Radwan, Tarek S. Ibrahim, & Tarek M. Ibrahim. (2023). Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance. MDPI AG.
Chicago Style (17th ed.) CitationMohamed S. Attia, Mohamed F. Radwan, Tarek S. Ibrahim, and Tarek M. Ibrahim. Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance. MDPI AG, 2023.
MLA (9th ed.) CitationMohamed S. Attia, et al. Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.